IMMU-67. UNLOCKING THE PROMISE OF MYXOMA VIRUS THERAPY: COMBINATION OF RADIATION PLUS CRIZOTINIB OR BEVACIZUMAB TO ENHANCE EFFICACY IN GLIOBLASTOMA

Glioblastoma (GB) is the most common and highly aggressive adult brain cancer. Dysfunction of receptor tyrosine kinases, such as ALK, c-Met and VEGF have all been implicated in the progression of this malignancy and resistance to therapy. Traditional therapeutic strategies targeting ALK/c-Met or VEG...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Das, Arabinda, Bartee, Eric, Oletsky, Jennifer, McDonald, Daniel G, Vandergrift, William Alexander, Varma, Abhay K, Vanek, Kenneth N, Giglio, Pierre, Patel, Sunil J, Lindhorst, Scott M, Cachia, David
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692398/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.524
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia